Slide 1 1 Cholesterol, Cholesterol Therapies, and Cholesterol Guidelines Andrew P. DeFilippis, Ty J. Gluckman, James Mudd, Catherine Campbell, Vera Bittner, Gregg Fonarow…

Slide 1 Cardiovascular Risk Factor Overview and Management Nathan D. Wong, PhD, FACC Associate Professor and Director, Heart Disease Prevention Program, University of California,…

Slide 1 Obesity and Health Slide 2 Trends in obesity Why people become obese Are we succeeding in managing obesity? Other illnesses associated with obesity Good diet for…

Slide 1 CIGARETTE SMOKING, CARDIOVASCULAR DISEASE RISK, AND IMPLEMENTATION STRATEGIES FOR SMOKING CESSATION Adapted and Modified from: Luepker RV, Lando HA. Tobacco Use and…

Slide 1 Coronary Heart Disease (CHD): A Disease of Affluence Slide 2 Lesson Objectives 1.I understand what CHD is 2.I understand what ‘affluence’ factors contribute to…

Slide 1 Slide 2 Antidyslipidemic drugs ( Summary ) Assoc. Prof. Iv. Lambev E-mail: [email protected] www.medpharm-sofia.eu Slide 3 CVD (cardiovascular disease) CVD (cardiovascular…

Slide 1 Global impact of ischemic heart disease World Heart Federation, 2011 Slide 2 The Problems Despite recent advances in treatment, cardiovascular disease (CVD) remains…

Slide 1 LDL-C target levels (mg/dL)  2 RF: ATP III: Risk Categories, LDL-C Goals ATP III: The Metabolic Syndrome* 102 cm (>40 in) >88 cm (>35 in) Men Women …

Slide 1 Obesity and Dyslipidemia AR Esteghamati, MD Associate Professor of Internal Medicine Endocrinology and Metabolism Research Center Tehran University of Medical Sciences…

Slide 1 Mendelian Randomization: Genes as Instrumental Variables David Evans University of Queensland Slide 2 This Session What is Mendelian Randomization (MR)? Examples…